Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19

The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) rapidly turned into an unprecedented pandemic of coronavirus disease 2019 (COVID-19). This global healthcare emergency marked the third occurrence of a deadly coronavirus (CoV) into the human society after entering the...

Full description

Bibliographic Details
Main Authors: Wen Cui, Kailin Yang, Haitao Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Molecular Biosciences
Subjects:
SARS-CoV-2
COVID-19
main protease
repurposed drugs
ab initio drug design
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2020.616341/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2020.616341/full

Similar Items